Real-world evidence on valproate vs levetiracetam retention in juvenile myoclonic epilepsy: a systematic review and meta-analysis
Background: Juvenile myoclonic epilepsy (JME) is a genetic generalized epilepsy syndrome with onset typically in adolescence and a chronic course requiring long-term antiseizure medications (ASMs). Valproate (VPA) is the most effective treatment for seizure control in JME but use is limited by metabolic, cognitive, and...